Long-Acting Reversible Contraceptives Await “Obamacare” Boost

Contraception coverage mandated by the Affordable Care Act could unlock demand for IUDs. Actavis aims to provide an alternative to Bayer’s hormone-eluting IUD in 2014; public sector rights to Levosert are assigned to nonprofit Medicines360.